Rose Therapeutics, Inc.

New Filing
CIK: 0001944189·Biotechnology·DELAWARE·Filed: Sep 2, 2022
Total Offering

$1,000,000

Amount Sold

$650,000

Investors

5

First Sale

Aug 22, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Matthew Wotiz
Related Person
Timothy Langloss
Related Person
Ira Sanders
Related Person

Company

Rose Therapeutics, Inc.

20 WEST MAIN STREET, 3RD FLOOR

NORRISTOWN, PA, 19401

917-453-2647

SEC Filing

0001944189-22-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Rose Therapeutics, Inc. Form D Filing — $1,000,000 | FilingFlow